James Charles Goss's questions to Regencell Bioscience Holdings (RGC) leadership • Q2 2016
Question
James Charles Goss of Barrington Research Associates, Inc. asked about capacity utilization in reseated theatres, reseating opportunities in smaller markets, and whether the ability to reseat proprietary RPX screens makes them more attractive than IMAX screens.
Answer
Executive VP, CFO & Treasurer David H. Ownby confirmed anecdotally that sold-out recliner screens are shifting customer traffic to off-peak times, which is a positive trend. Chairman & CEO Amy E. Miles noted that while they have more flexibility with their own RPX screens and see 'promising results' from reseating them, discussions with IMAX about their auditoriums are ongoing.